Abstract is: In immunology, the term sensitization is used for the following concepts: * Immunization by inducing an adaptive response in the immune system. In this sense, sensitization is the term more often in usage for induction of allergic responses. * To bind antibodies to cells such as erythrocytes in advance of performing an immunological test such as a complement-fixation test or a Coombs test. The antibodies are bound to the cells in their Fab regions in the preparation. * To bind antibodies or soluble antigens chemically or by adsorption to appropriate biological entities such as erythrocytes or particles made of gelatin or latex for passive aggregation tests. Those particles themselves are biologically inactive except for serving as antigens against the primary antibodies or as carriers of the antigens. When antibodies are used in the preparation, they are bound to the erythrocyte or particles in their Fab regions. Thus the step follows requires the secondary antibodies against those primary antibodies, that is, the secondary antibodies must have binding specificity to the primary antibodies including to their Fc regions.
allergy | Q42982 |
P1417 | Encyclopædia Britannica Online ID | science/sensitization-medicine |
P2671 | Google Knowledge Graph ID | /g/12176616 |
/g/121srf6c | ||
P6366 | Microsoft Academic ID | 2909330029 |
P2892 | UMLS CUI | C3839736 |
Q21174246 | 1-dodecanethiol exposure |
Q21175035 | 1-pentanethiol exposure |
Q21174746 | 2-methyl-2,4-pentanediol exposure |
Q21174156 | 3,3'-dichlorobenzidine exposure |
Q21173335 | N-butyl glycidyl ether exposure |
Q21281647 | abrin exposure |
Q21167527 | acetic acid exposure |
Q21167640 | acrylic acid exposure |
Q21167894 | atrazine exposure |
Q21174296 | aziridine exposure |
Q21167929 | benomyl exposure |
Q21173347 | calcium cyanamide exposure |
Q21173356 | caprolactam exposure |
Q21173357 | captafol exposure |
Q21173358 | captan exposure |
Q21173543 | catechol exposure |
Q21173554 | chloroacetaldehyde exposure |
Q21174123 | cyclohexanamine exposure |
Q21174183 | diethylenetriamine exposure |
Q21174292 | ethylene glycol exposure |
Q21175067 | exposure to soluble platinum salts |
Q21174343 | glutaraldehyde exposure |
Q21174762 | hydroquinone exposure |
Q21174794 | isopropyl glycidyl ether exposure |
Q21174912 | methylene bis(4-cyclohexylisocyanate) exposure |
Q21175045 | phenyl glycidyl ether exposure |
Q21175046 | phenylhydrazine exposure |
Q21175064 | piperazine dihydrochloride exposure |
Q21175376 | toluene diisocyanate exposure |
Q21175403 | turpentine exposure |
Q23918380 | A combined murine local lymph node and irritancy assay to predict sensitization and irritancy potential of chemicals |
Q119012558 | A cross sectional study of respiratory and allergy status in dairy workers |
Q23918807 | A field method for near real-time analysis of perchloroethylene in end-exhaled breath |
Q24170254 | A four-year prospective study to evaluate the efficacy of glove interventions in preventing natural latex sensitization in healthcare workers at two hospitals |
Q23912077 | A laboratory investigation of the effectiveness of various skin and surface decontaminants for aliphatic polyisocyanates |
Q25893484 | A multistate outbreak of Salmonella enterica serotype typhimurium infection linked to raw milk consumption--Ohio, 2003 |
Q66593151 | A preventive program for decreasing sensitization in beryllium workers |
Q23921379 | Adjuvant effect of zymosan after pulmonary treatment in a mouse ovalbumin allergy model |
Q77790776 | Age-dependent pulmonary reactivity to house dust mite allergen: a model of adult-onset asthma? |
Q23910521 | Airborne fungal fragments and allergenicity |
Q24824818 | Airway responses after specific challenge of rats sensitized via skin exposure to trimellitic anhydride (TMA) |
Q23923937 | Airway responses in Brown Norway rats following inhalation sensitization and challenge with trimellitic anhydride |
Q64078735 | Allergen Sensitization and Asthma Outcomes among World Trade Center Rescue and Recovery Workers |
Q23913402 | Allergen concentration in natural rubber latex |
Q24169952 | Allergen concentration in natural rubber latex |
Q23913403 | Allergen concentration in natural rubber latex (Clin Exp Allergy 36(8):1078 - correction) |
Q41571466 | Allergenicity to Cannabis sativa L. and methods to assess personal exposure |
Q23911164 | Allergic airway inflammation is differentially exacerbated by daytime and nighttime ultrafine and submicron fine ambient particles: heme oxygenase-1 as an indicator of PM-mediated allergic inflammation |
Q95855878 | Allergic and Respiratory Symptoms in Employees of Indoor Cannabis Grow Facilities |
Q24170398 | Allergic and latex-specific sensitization: route, frequency, and amount of exposure that are required to initiate IgE production |
Q25932315 | Alteration of allergic response following an acute pulmonary exposure to nickel oxide nanoparticles in a murine OVA asthma model |
Q64137208 | Alternaria is associated with asthma symptoms and exhaled NO among NYC children |
Q57102138 | Ambient particulate matter enhances the pulmonary allergic immune response to house dust mite in a BALB/c mouse model by augmenting Th2- and Th17-immune responses |
Q25892271 | American College of Chest Physicians issues consensus statement on diagnosing and treating work-related asthma |
Q23912078 | An FTIR investigation of isocyanate skin absorption using in vitro guinea pig skin |
Q29010322 | An animal model of adult-onset allergic asthma |
Q41571386 | An official American Thoracic Society workshop report: presentations and discussion of the Sixth Jack Pepys Workshop on Asthma in the Workplace |
Q24169790 | Analysis of available diagnostic tests for latex sensitization in an at-risk population |
Q107001868 | Analysis of single nucleotide polymorphisms in chronic beryllium disease |
Q26339759 | Animal models and mechanisms of latex allergy |
Q23921643 | Antibody-independent complement activation by cardroom cotton dust |
Q107002032 | Antimicrobials and allergic disease: identifying novel biomarkers and mechanisms of action |
Q24719247 | Application of data from animal toxicity testing and alternative methods in assignment of skin notations |
Q57272944 | Application of moisturizer to neonates prevents development of atopic dermatitis |
Q23921328 | Application of the random forest method in studies of local lymph node assay based skin sensitization data |
Q26339684 | Assessment of a modified local lymph node assay to evaluate the irritancy/sensitization potential of chemicals exposed to breached skin |
Q99415646 | Association between lone star tick bites and increased alpha-gal sensitization: evidence from a prospective cohort of outdoor workers |
Q27908640 | Association of MHC region SNPs with irritant susceptibility in healthcare workers |
Q77790265 | Associations of metrics of peak inhalation exposure and skin exposure indices with beryllium sensitization at a beryllium manufacturing facility |
Q29010345 | Asthma control, treatment patterns, and self-management among WTC rescue and recovery workers |
Q57051713 | Authors' response |
Q26154901 | Baker's asthma |
Q24995245 | Beryllium disease |
Q23913231 | Beryllium exposure: dermal and immunological considerations |
Q23915962 | Beryllium: a modern industrial hazard |
Q29009018 | Beryllium: hazard alert |
Q23913233 | Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model |
Q119013235 | Biomass smoke exposure and atopy among young children in the western highlands of Guatemala: a prospective cohort study |
Q23918163 | C57BL/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivity |
Q24703893 | CCL2 KO mice demonstrate enhanced TH2 responses following dermal sensitization |
Q25112810 | Case-by-case assessment of adult-onset asthma attributable to occupational exposures among members of a health maintenance organization |
Q24849318 | Cellular and humoral factors in a subchronic model of toluene diisocyanate-induced (TDI) asthma |
Q23918262 | Characterisation of wet work and glove use in healthcare occupations |
Q23917246 | Characteristics of beryllium exposure to small particles at a beryllium production facility |
Q23918567 | Characterization and comparative analysis of 2,4-toluene diisocyanate and 1,6-hexamethylene diisocyanate haptenated human serum albumin and hemoglobin |
Q26206590 | Characterization and comparison of methylene diphenyl diisocyanate haptenated human serum albumin and hemoglobin |
Q24169795 | Characterization of Cannabis sativa allergens |
Q119013094 | Characterization of cleaning and disinfection product use, glove use, and skin disorders by healthcare occupations in a midwestern healthcare facility |
Q66666411 | Characterization of methylene diphenyl diisocyanate haptenated human serum albumin and hemoglobin |
Q23909683 | Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease |
Q24170387 | Chemical activation of innate and specific immunity in contact dermatitis |
Q23921462 | Chromium complexes with proteins and mucopolysaccharides and their relationship to chromium allergy in sensitized guinea pigs |
Q66587312 | Chromium sensitization in an artist's workshop |
Q23916117 | Chronic beryllium disease and sensitization at a beryllium processing facility |
Q26237341 | Chronic beryllium disease and sensitization at a beryllium processing facility |
Q23917118 | Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove |
Q23917120 | Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove |
Q24169988 | Clinical relevance of the Hevea brasiliensis lipid transfer protein Hev b 12 |
Q23920112 | Comparison of NiSO4 and NiCl2 as sensitizers in the guinea pig |
Q39379802 | Comparison of biological effects with albumin adducts of 4,4'-methylenediphenyl diisocyanate in workers |
Q23918348 | Comparison of mouse strains using the local lymph node assay |
Q23918222 | Comparison of murine assays for the identification of chemical sensitizers |
Q26339555 | Comparison of murine models for the identification of potential chemical sensitizers |
Q26339700 | Comparison of pulmonary response to inhaled and intratracheally instilled diesel exhaust particulate |
Q23917252 | Considerations of peak exposure indices for the epidemiology of beryllium sensitization |
Q77792223 | Contribution of antimicrobials to the development of allergic disease |
Q26375448 | Controles de peligro de NIOSH HC28 - Control de riesgos químicos durante la aplicación de uñas postizas |
Q23924383 | Controlling chemical hazards during the application of artificial fingernails |
Q26349298 | Controlling chemical hazards in the nail salon industry |
Q24849207 | Cumulative incidence of chronic beryllium disease in a ceramics factory cohort |
Q23915724 | Dermal exposure to 3-amino-5-mercapto-1,2,4-triazole (AMT) induces sensitization and airway hyperreactivity in BALB/c mice |
Q24091383 | Dermal exposure to the commonly used antimicrobial chemical triclosan promotes allergic responses in skin and lung (HYP7P.317) |
Q24706740 | Dermal exposure to triclosan induces changes in expression of innate and adaptive immune genes in a mouse model |
Q24718330 | Development of a computer database of skin sensitizers |
Q25017420 | Development of new QSAR approaches in occupational contact dermatitis |
Q23913502 | Development of sensitive immunoassays for the detection of the glucuronide conjugate of 3-phenoxybenzyl alcohol, a putative human urinary biomarker for pyrethroid exposure |
Q24170258 | Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-specific IgE antibody. The multi-center latex skin testing study task force |
Q24706572 | Differences in dissolution behavior in a phagolysosomal simulant fluid for single-component and multi-component beryllium materials associated with beryllium sensitization and chronic beryllium disease |
Q23909680 | Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease |
Q26158575 | Differential expression kinetics of miRNA involved in allergic chemical sensitization following dermal exposure in a murine model |
Q24717596 | Dissolution of finely divided single-constituent and multiconstituent beryllium aerosol materials associated with beryllium sensitization and chronic beryllium disease |
Q47583803 | Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide. |
Q24703177 | Do indicators of beryllium skin exposure predict beryllium sensitization? |
Q61955812 | Does Acupuncture Activate Endogenous Pain Inhibition in Chronic Whiplash? |
Q23918704 | Dose-dependent thiol and immune responses to ovalbumin challenge in Brown Norway rats |
Q23923852 | Dose-response and time course of specific IgE and IgG after single and repeated topical skin exposure to dry trimellitic anhydride powder in a Brown Norway rat model |
Q29009470 | Dry cutting & grinding is risky business |
Q24826321 | Educating beryllium workers about genetic information |
Q26059290 | Efectos de las sustancias químicas al contacto con la piel: lo que deben saber los trabajadores |
Q23910872 | Effect of diesel exhaust particles on allergic reactions and airway responsiveness in ovalbumin-sensitized Brown Norway rats |
Q26343222 | Effect of subchronic dermal application of O-ethyl O-4-nitrophenyl phenylphosphonothioate on producing delayed neurotoxicity in hens |
Q61924426 | Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. |
Q24718971 | Effects of skin contact with chemicals: guidance for occupational health professionals and employers |
Q24631265 | Effects of skin contact with chemicals: what a worker should know |
Q24704524 | Effects of static compression on the vibration modes of a fingertip |
Q24719433 | Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant |
Q36451943 | Elevated urine arsenic: un-speciated results lead to unnecessary concern and further evaluations |
Q23916393 | Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers |
Q66666405 | Enrichment and measurement of a signature MDI human serum albumin peptide adduct |
Q26323773 | Environmental survey of occupational exposure to aerosolized egg allergens in the egg processing industry |
Q26342917 | Erratum: surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments - California, Massachusetts, Michigan, and New Jersey, 1993-1995 |
Q24353900 | Evaluation of IL-9, IL-10, IL-13 and IL-15 as biomarkers of dermal exposure to respiratory sensitizers |
Q23919883 | Evaluation of a preventive program to reduce sensitization at a beryllium metal, oxide, and alloy production plant |
Q24707170 | Evaluation of dermal sensitization to Western Red Cedar extract and abietic acid using the local lymph node assay |
Q26339551 | Evaluation of human irritants and weak to moderate sensitizers using a modified LLNA and an irritancy/phenotyping assay |
Q24631486 | Evaluation of irritancy and the sensitization potential of metal working fluids and metal working fluid components |
Q77790585 | Evaluation of laser coding particulate composition, health effects, and safety climate at a brewery |
Q23911380 | Evaluation of the NIOSH draft method 5525 for determination of the total reactive isocyanate group (TRIG) for aliphatic isocyanates in autobody repair shops. National Institute for Occupational Safety and Health |
Q23921560 | Evaluation of the contact and respiratory sensitization potential of volatile organic compounds generated by simulated indoor air chemistry |
Q24825536 | Evaluation of the contact hypersensitivity-inducing potential of a commercial weapon cleaning and maintenance compound |
Q25929990 | Evaluation of the dermal sensitization potential of 3-amino-5- mercapto-1,2,4-triazole and n-(2,6-difluorophenyl)-5-methyl)1,2,4) triazolo-(1,5a)-pyrimidine-2-sulfonamide |
Q27908639 | Evaluation of the irritancy and hypersensitivity potential following topical application of didecyldimethylammonium chloride |
Q24170356 | Evaluation of the prevalence of antiwheat-, anti-flour dust, and anti-alpha-amylase specific IgE antibodies in US blood donors |
Q24266092 | Evaluation of the sensitization potential of two chemicals, methyl red and basic fuchsin, with potential use in indicator pads |
Q24351820 | Evaluation of the sensitization potential of two lubricant additives, phenyl-alpha-naphthylamine and alkylated phenyl-alpha-naph |
Q26329403 | Evaluation of the skin's role in natural rubber latex induced hypersensitivity |
Q24091382 | Exploring the role of miRNA 210 and regulatory T cells during TDI sensitization (HYP6P.270) |
Q23915013 | Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma |
Q24704228 | Exposure assessment at a beryllium ceramics facility following implementation of a dermal protection program |
Q23910873 | Exposure of Brown Norway rats to diesel exhaust particles prior to ovalbumin (OVA) sensitization elicits IgE adjuvant activity but attenuates OVA-induced airway inflammation |
Q23912469 | Exposure to flour dust and sensitization among bakery employees |
Q23917719 | Exposure to protein aeroallergens in egg processing facilities |
Q119012977 | Exposure to the antimicrobial chemical triclosan disrupts keratinocyte function and skin integrity in a model of reconstructed human epidermis (dataset) |
Q115074862 | Exposure to the immunomodulatory chemical triclosan differentially impacts immune cell populations in the skin of haired (BALB/c) and hairless (SKH1) mice |
Q119012759 | Exposure to the immunomodulatory chemical triclosan differentially impacts immune cell populations in the skin of haired (BALB/c) and hairless (SKH1) mice (dataset) |
Q23921574 | Expression kinetics of miRNA involved in dermal toluene 2,4-diisocyanate sensitization |
Q52716104 | Farnesyltransferase Inhibition Exacerbates Eosinophilic Inflammation and Airway Hyperreactivity in Mice with Experimental Asthma: The Complex Roles of Ras GTPase and Farnesylpyrophosphate in Type 2 Allergic Inflammation. |
Q25930239 | Fatal asthma from powdering shark cartilage and review of fatal occupational asthma literature |
Q23917717 | Federal government regulation of occupational skin exposure in the USA |
Q29960427 | Fine particulate matter (PM2.5) enhances allergic sensitization in BALB/c mice |
Q23916387 | Flu-like illness among workers at a soy processing plant |
Q25891668 | Frequency of sensitization and disease among workers in beryllium service and distribution centers |
Q92869175 | Frequency-dependent changes in mitochondrial number and generation of reactive oxygen species in a rat model of vibration-induced injury |
Q24720730 | Genetic susceptibility and occupational exposure to beryllium |
Q23916053 | Genetic susceptibility testing for beryllium: worker knowledge, beliefs, and attitudes |
Q26237328 | Genetic susceptibility testing for beryllium: worker knowledge, beliefs, and attitudes |
Q26248517 | Graphene oxide augments airway remodeling and hyperresponsiveness in a murine model of asthma |
Q24848096 | Guía de salud ocupacional para profesionales de la salud y empleadores |
Q26353043 | HHE Determination Report No. HHE-75-147-318, Westinghouse Electric Corporation |
Q26351990 | HHE HHE-72-22-31-34-24, Bendix Corporation, Kansas City, Missouri |
Q26347825 | HHE Report No. HETA-81-466-1591, Electric Machinery - McGraw Edison Company, Minneapolis, Minnesota |
Q26350281 | HHE Report, No. HETA-82-176-1236, U. S. Customs Service, Patrol Division Office, Treasure Island, San Francisco, California |
Q26348596 | HHE determination report no. HHE-73-30-90, King Seeley Thermos Company, Macomb, Illinois |
Q26349201 | HHE determination report no. HHE-74-84-188, Cosmo Plastics Company, Fredericksburg, Ohio |
Q26354996 | HHE determination report no. HHE-79-86-675, Tufts Medical School, Boston, Massachusetts |
Q26351684 | HHE report HHE-72-84-31, Dunham-Bush, Inc., West Hartford, Connecticut |
Q26351506 | HHE report no. HETA-94-0373-2480, Suffolk County Courthouse, Boston, Massachusetts |
Q26341772 | HLA-A1 and coalworkers' pneumoconiosis |
Q108918124 | HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease |
Q26374787 | Hazards of ethyl methacrylate |
Q26155162 | Health care workers and asthma: 'occupational asthma' is a risk for nurses |
Q115075347 | Health effects of exposure to cannabis in workers in an indoor growing facility |
Q24847088 | Health hazard evaluation report: HETA-2007-0261-3122, evaluation of contact dermatitis among ink ribbon manufacturing employees - New York |
Q26355279 | Health hazard evaluation report: HETA-81-146-1162, Ralston Purina Company, Mechanicsburg, Pennsylvania |
Q26346693 | Health hazard evaluation report: HETA-83-116-1570, Essex Group, Incorporated, Vincennes, Indiana |
Q26351161 | Health hazard evaluation report: HHE-80-065-780, Clorox Company, Jersey City, New Jersey |
Q24978010 | Health hazard evaluation report: evaluation of ortho-phthalaldehyde in eight healthcare facilities |
Q26206262 | Health hazard evaluation report: evaluation of sensitization and exposure to flour dust, spices, and other ingredients among poultry breading workers |
Q23918595 | Healthcare for obstructive lung disease in an industrial spirometry surveillance program |
Q29009815 | High impact: preventing occupational latex allergy in health care workers |
Q23917588 | Histamine release from human lung by a component of cotton bracts |
Q26206451 | Home enviroment and childhood asthma in a rural Iowa county |
Q23919596 | How to improve skin notation. Position paper from a workshop |
Q66651662 | Identification of immunologic and genetic biomarkers for TMA sensitization |
Q66664876 | Identification of immunologic and genetic biomarkers for TMA sensitization |
Q23916595 | Identification of phenolic dermal sensitizers in a wound closure tape |
Q24169948 | Identifying domestic aeroallergen exposure in a cystic fibrosis patient: a case study |
Q29010117 | IgE antibodies to fungi among asthmatic children living in homes damaged by Hurricane Sandy in New York City |
Q23909597 | Immunogenetic factors in beryllium sensitization and chronic beryllium disease |
Q24719062 | Immunogenetics factors in chronic beryllium disease |
Q64126006 | Immunological methods for diagnosis and monitoring of IgE-mediated allergy caused by industrial sensitizing agents (IMExAllergy) |
Q23918378 | Immunological responses of mice following administration of natural rubber latex proteins by different routes of exposure |
Q24170252 | Immunological responses of mice following administration of natural rubber latex proteins by different routes of exposure |
Q24979909 | Immunomodulation of the IGE response to natural rubber latex (NRL) proteins by endotoxin and glutaraldehyde |
Q66670915 | Immunoregulatory responses in Trimellitic Anhydride occupational sensitization |
Q66671704 | Immunoregulatory responses in Trimellitic Anhydride occupational sensitization |
Q23913353 | In Vitro Dermal Penetration of 4-Chloro-3-Methylphenol from Commercial Metal Working Fluid and Aqueous Vehicles |
Q29009204 | In vitro assay for hapten-specific priming of human T lymphocytes |
Q23917589 | In vitro histamine release from human lung as a model for the acute response to cotton dust |
Q32944506 | In-depth survey report: spray polyurethane foam chemical exposures during spray application, Priority 1, Cincinnati, Ohio |
Q23913773 | Increased cell proliferation in spleen and lymph nodes peripheral to contact allergen application site |
Q26237118 | Increased cell proliferation in spleen and lymph nodes peripheral to contact allergen application site |
Q25017381 | Increased expression and immunoregulatory potential of microRNA 210 in a murine model of TDI sensitization |
Q24169977 | Increasing the ability to correctly identify latex sensitized patients using serologic tests |
Q23920199 | Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease |
Q23912804 | Induction and localization of cutaneous interleukin-1 beta mRNA during contact sensitization |
Q23919329 | Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed |
Q23917019 | Influence of MHC CLASS II in susceptibility to beryllium sensitization and chronic beryllium disease |
Q24706785 | Inhalation exposure of trimellitic anhydride (TMA) aerosol in a brown norway rat model |
Q23923300 | Inhibitor of nuclear factor kB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic |
Q23909535 | Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions |
Q37182615 | Investigating the Effects of Particulate Matter on House Dust Mite and Ovalbumin Allergic Airway Inflammation in Mice |
Q24719199 | Irritancy and allergic responses induced by topical application of didecyldimethylammonium chloride |
Q23921557 | Irritancy and sensitization potential of glyoxylic acid |
Q26206854 | Isocyanate sensitization: a cross sectional study of MDI exposure and effects in the production of polyurethane coated fabrics |
Q26155199 | Job-related risk of beryllium disease at a beryllium copper alloy facility |
Q24703714 | Late-phase airway response to trimellitic anhydride in Brown Norway rat: effect of dexamethasone and salbutamol |
Q26248475 | Latex allergy in the workplace |
Q23917811 | Latex allergy in the workplace |
Q23910860 | Latex allergy symptoms among health care workers: results from a university health and safety surveillance system |
Q23919330 | Letter to the editor: prevention of beryllium sensitization and chronic beryllium disease |
Q24994057 | Local lymph node assay as a quantitative risk assessment tool to model biologic skin response of allergic contact dermatitis in the mouse |
Q24169789 | London Plane Tree bioaerosol exposure and allergic sensitization in Sydney, Australia |
Q23910902 | Long-term efficacy of a program to prevent beryllium disease |
Q29010150 | Longitudinal asthma patterns in a large cohort of US women with 22-Year follow-up |
Q24255396 | Lung antigen induced cell-mediated immune injury in chronic respiratory diseases |
Q24706589 | Lung toxicity and allergy responses in mice exposed to nanoparticle silver |
Q29010149 | Medication use among individuals with work-related asthma, Asthma Call-back Survey, 2012-2013 |
Q77791988 | Metal nanomaterials: immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease |
Q23914627 | Migration of beryllium via multiple exposure pathways among work processes in four different facilities |
Q24706559 | Models vs. measurement. Are we on the right track? The promise and limitations of occupational exposure banding |
Q26339561 | Murine immune responses to natural rubber latex proteins |
Q26373682 | NIOSH hazards controls HC28 - controlling chemical hazards during the application of artificial fingernails |
Q26206278 | NIOSH skin notation (SK) profile: 1,3-dichloropropene (1,3-D) [CAS No. 542-75-6] |
Q26060146 | NIOSH skin notation (SK) profile: 2-butoxyethanol (BE) [CAS No. 111-76-2] |
Q25930007 | NIOSH skin notation (SK) profile: 2-ethoxyethanol (EE) [CAS No. 110-80-5] |
Q24718539 | NIOSH skin notation (SK) profile: acrylamide [CAS No. 79-06-1] |
Q25114240 | NIOSH skin notation (SK) profile: acrylonitrile [CAS No. 107- 13-1] |
Q25106553 | NIOSH skin notation (SK) profile: bisphenol A (BPA) [CAS No. 80-05-7] |
Q25892238 | NIOSH skin notation (SK) profile: dinitrobenzene (DNB) [CAS No. 25154-54-5]; m-dinitrobenzene (m-DNB) [CAS No. 99-65-0]; o-dinitrobenzene (o-DNB) [CAS No. 528-29-0] p-dinitrobenzene (p-DNB) [CAS No. 100-25-4] |
Q24718604 | NIOSH skin notation (SK) profile: dinitrotoluene [CAS No. 25321-14-6]; 2,4-dinitrotoluene (2,4-DNT) [CAS No. 121-14-2]; 2,6-dinitrotoluene (2,6-DNT) [CAS No. 606-20-2] |
Q25932913 | NIOSH skin notation (SK) profile: epichlorohydrin [CAS No. 106- 89-8] |
Q24725268 | NIOSH skin notation (SK) profile: ethylene glycol dinitrate (EGDN) [CAS No. 628-96-6] |
Q25930054 | NIOSH skin notation (SK) profile: formaldehyde/formalin [CAS No. 50-00-0] |
Q25112551 | NIOSH skin notation (SK) profile: glutaraldehyde [CAS No. 111- 30-8] |
Q24266379 | NIOSH skin notation (SK) profile: hydrazine [CAS No. 302-01-2] |
Q24847464 | NIOSH skin notation (SK) profile: hydrogen fluoride/hydrofluoric acid (HF) [CAS No. 7664-39-3] |
Q26206648 | NIOSH skin notation (SK) profile: methyl cellosolve [CAS No. 109-86-4] |
Q26155250 | NIOSH skin notation (SK) profile: nitroglycerin [CAS No. 55-63- 8] |
Q26056188 | NIOSH skin notation (SK) profile: nonane [CAS No. 111-84-2] |
Q26059320 | NIOSH skin notation (SK) profile: p-phenylene diamine [CAS No. 106-50-3] |
Q24363097 | NIOSH skin notation (SK) profile: phenol [CAS No. 108-95-2] |
Q25930236 | NIOSH skin notation (SK) profile: sodium hydroxide (NaOH) [CAS No. 1310-73-2] |
Q115075071 | NIOSH skin notation profile: 2,4-toluene diisocyanate (2,4-TDI), 2,6-toluene diisocyanate (2,6-TDI), 2,4- and 2,6-toluene diisocyanate mixture |
Q77796936 | NIOSH skin notation profile: atrazine |
Q115075073 | NIOSH skin notation profile: beta-chloroprene |
Q77790337 | NIOSH skin notation profile: catechol |
Q89716501 | NIOSH skin notation profile: chlorinated camphene |
Q105468939 | NIOSH skin notation profile: chlorodiphenyl (42% chlorine) |
Q115075069 | NIOSH skin notation profile: chlorodiphenyl (54% chlorine) |
Q105468940 | NIOSH skin notation profile: cyclohexanol |
Q105468942 | NIOSH skin notation profile: cyclohexanone |
Q105468943 | NIOSH skin notation profile: cyclonite |
Q115075072 | NIOSH skin notation profile: diacetyl and 2,3-pentanedione |
Q105468941 | NIOSH skin notation profile: diethylenetriamine (DETA) |
Q115075074 | NIOSH skin notation profile: dioxane |
Q77790329 | NIOSH skin notation profile: pentachlorophenol (PCP) |
Q77790333 | NIOSH skin notation profile: sodium fluroacetate |
Q26340729 | Natural rubber latex: glove use, sensitization, and airborne and latent dust concentrations at a Denver hospital |
Q62811588 | Neurophysiological Validation of the Clinical Criteria of Sensitization in Chronic Pelvic and Perineal Pain Population |
Q29008723 | New sampling and analysis method for isocyanates |
Q77789706 | Novel cutaneous mediators of chemical allergy |
Q112237455 | OSHA's beryllium OEL: inadequacy and urgent need for a new standard, the case of recycling operations and dental technicians |
Q26323770 | Occupational asthma and rhinitis among egg-processing workers |
Q89710285 | Occupational asthma: in and out of the workplace conference, April 30 - May 2, 1998, Morgantown, West Virginia |
Q23924468 | Occupational exposure to "environmentally-friendly" spray foam insulation associated with isocyanate immune responses and asthmatic symptoms |
Q29008804 | Occupational health and funeral homes |
Q24250674 | Occupational latex asthma |
Q23910218 | Occupational sensitization to soy allergens in workers at a processing facility |
Q23918217 | Occupational use of insecticides, fungicides and fumigants and risk of non-Hodgkin lymphoma and multiple myeloma in the Agricultural Health Study |
Q23909313 | Ovalbumin aeroallergen exposure-response in brown Norway rats |
Q26328908 | Oxidative stress and hypersensitivity response to phenolic haptens |
Q25891873 | Parental atopy and asthma in rural children: is there a link? |
Q26207025 | Particle penetration of the skin as a route of sensitization in occupational lung disease |
Q24169974 | Performance of FDA-approved serologic testing for latex allergy in an at-risk population |
Q26343733 | Peroxidase/H2O2 enhances hypersensitivity responses induced by eugenol: inhibitory effect of an antioxidant, lipoic acid |
Q112235604 | Photothermal desorption of toluene from carbonaceous substrates using light flash |
Q23909687 | Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment |
Q23912076 | Polyisocyanates in occupational environments: a critical review of exposure limits and metrics |
Q115075107 | Population-based genetic model for diisocyanate-induced asthma |
Q24350875 | Potential for immune sensitization following dermal exposure to indium tin oxide |
Q23921552 | Potential immunotoxicological health effects following exposure to COREXIT 9500A during cleanup of the Deepwater Horizon oil spill |
Q25932957 | Practical impact of programmatic research results in the beryillium industry |
Q23917577 | Prevalence of beryllium sensitization among Department of Defense conventional munitions workers at low risk for exposure |
Q25930344 | Prevención de la sensibilización y la enfermedad por exposición al berilio |
Q25932371 | Preventing sensitization and disease from beryllium exposure |
Q26153691 | Preventive program reduces sensitization in beryllium workers |
Q23912103 | Prior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic damage induced by a neurotoxic regimen |
Q23911118 | Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility |
Q23919983 | Pulmonary hyperreactivity in cynomolgus monkeys (Macaca fascicularis) from nose-only inhalation exposure to disodium hexachloroplatinate, Na2PtCl6. |
Q23913776 | Pyridoxylamine reactivity kinetics as an amine based nucleophile for screening electrophilic dermal sensitizers |
Q24999291 | Pyridoxylamine reactivity kinetics as an amine-based probe for screening electrophilic contact allergens |
Q26158766 | QSAR models of allergic contact dermatitis |
Q26159068 | Quartz exposure can cause pneumoconiosis in coal workers. |
Q37573667 | Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. |
Q66672626 | Reduce silica exposure during jackhammer work: use a simple water-spray dust control |
Q23909398 | Release of beryllium from beryllium-containing materials in artificial skin surface film liquids |
Q23918028 | Release of beryllium from mineral ores in artificial lung and skin surface fluids |
Q23909690 | Release of beryllium into artificial airway epithelial lining fluid |
Q77791421 | Respiratory health, allergies, and the farm environment: design, methods and enrollment in the observational Wisconsin Infant Study Cohort (WISC): a research proposal |
Q23909943 | Respiratory toxicologic pathology of inhaled diacetyl in Sprague-Dawley rats |
Q24170296 | Restraint stress applied prior to chemical sensitization modulates the development of allergic contact dermatitis differently than restraint prior to challenge |
Q26339734 | Restraint stress modifies DNCB-induced lymph node cytokine production, but not T cell proliferation |
Q26059347 | Restraint stress modifies Langerhans cell migration and lymph node cell proliferation |
Q25891715 | Restraint stress modulation of ear swelling in ACD is independent of sensitizing dose of chemical |
Q23918161 | Restraint-induced modulation of allergic and irritant contact dermatitis in male and female B6.129 mice |
Q105468460 | Risk assessment for toluene diisocyanate and respiratory disease human studies |
Q25933082 | Risk of beryllium disease among short-term and long-term workers at a metal, oxide, and alloy production plant |
Q83381191 | Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era |
Q26341101 | Role of sensitization routes in the development of type I hypersensitivity to natural rubber latex in mice |
Q26160376 | Role of tumor necrosis factor in toluene diisocyanate asthma |
Q24846953 | Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers |
Q23917217 | Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction |
Q23914847 | Sensitization and chronic beryllium disease at a primary manufacturing facility, part 2: validation of historical exposures |
Q23911117 | Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers |
Q23911120 | Sensitization and disease from exposure to soluble and insoluble beryllium at a primary manufacturing facility |
Q66587326 | Sensitization of laundry-products workers to proteolytic bacterial enzymes - New Jersey |
Q66643093 | Sensory nerve ending structures after 5 weeks of vibration exposure |
Q29010148 | Serum IgE levels among U.S. workers - National Health and Nutrition Examination Survey (NHANES), 2005-2006 |
Q23912974 | Setting occupational exposure limits for chemical allergens-understanding the challenges |
Q29009053 | Silicosis resources |
Q23920927 | Skin as a route of exposure and sensitization in chronic beryllium disease |
Q58093006 | Skin sensitization testing needs and data uses by US regulatory and research agencies |
Q66670890 | Spinal cord and systemic inflammation are linked with sickness behavior in aged rats performing a repetitive task |
Q25930715 | State of the science of occupational exposure limit methods and guidance |
Q29008347 | Stop silicosis in sandblasters use silica substitutes |
Q24169951 | Strict avoidance of exposure to natural rubber latex (NRL) glove products is associated with longitudinal reduction in percutaneous reactivity to NAL and hev B proteins |
Q23909564 | Structure-activity models for contact sensitization |
Q23921490 | Suppressed NF-kB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-a induced apoptosis in human cancer cells |
Q24630788 | Surface and skin decontamination of aliphatic isocyanates in an experimental study |
Q26342910 | Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments - California, Massachusetts, Michigan, and New Jersey, 1993-1995 |
Q25930620 | Symptom onset in the first two years of employment at a wood products plant: some observations relevant to occupational medical screening |
Q57102984 | TH17-Induced Neutrophils Enhance the Pulmonary Allergic Response Following BALB/c Exposure to House Dust Mite Allergen and Fine Particulate Matter From California and China |
Q23912630 | TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization |
Q57975142 | Test No. 406: Skin Sensitisation |
Q23911456 | Testing of glove efficacy against sprayed isocyanate coatings utilizing a reciprocating permeation panel |
Q23912625 | The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization |
Q26159026 | The effect of activating and deactivating substituents on the allergenicity of benzoquinone and benzoquinone derivatives |
Q24255397 | The effect of lung antibody on normal lung structure and function |
Q26329437 | The effects of an educational "Alert" on hospital policy making: communication, organizational change and occupational latex allergy |
Q29048395 | The feasibility of studying the health implications of surface beryllium contamination: a review of eight industries |
Q25930339 | The immunomodulatory potential of microRNA 210 and regulatory T cells in a murine model of chemical sensitization |
Q26343911 | The influence of the thyroid on the acute toxicity of a dynamite- sensitizing mixture (36135) |
Q23924476 | The relationship between HLA-DPB1, HLA-DRB1 and CBD/BeS |
Q77792734 | The role of elbow tender point examination in the diagnosis of lateral epicondylitis |
Q26339569 | The role of endotoxin in the development of latex allergy |
Q37981493 | The role of lymphocyte proliferation tests in assessing occupational sensitization and disease |
Q26329405 | The role of sensitization routes in the development of type I hypersensitivity to natural rubber latex in mice |
Q24584308 | Time course of specific antibody production following topical skin exposure to dry trimellitic anhydride (TMA) powder |
Q29008706 | To my doctor: What physicians need to know about silicosis in construction, demolition, and renovation workers |
Q26323363 | Topical skin exposure to dry trimellitic anhydride (TMA) powder induces specific IgE |
Q23909698 | Total-body exposure to metal sensitizers: inhalation, ingestion, and skin contact |
Q26339576 | Toughness of skin in arsenic exposed mice: role of GM-CSF and TGFa |
Q61918358 | Tramadol and Pain Sensitization |
Q23918210 | Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk |
Q24631226 | Use of a multidisciplinary approach that identified phenolic dermal sensitizers in a wound closure tape |
Q24850760 | Using workplace medical surveillance to evaluate a new preventive program in the beryillium industry: a model for the manufacturing sector |
Q23914846 | Validating historical beryllium exposure estimates at a beryllium manufacturing facility |
Q23916434 | Vibration disrupts vascular function in a model of metabolic syndrome |
Q29009153 | What dental technicians need to know about silicosis |
Q29008705 | What physicians need to know about occupational silicosis and silica exposure sources |
Q23919331 | Work-Related Reactive Airways Dysfunction Syndrome Cases from Surveillance in Selected US States |
Q26376927 | Work-related asthma |
Q119014439 | Work-related asthma |
Q126365319 | Work-related asthma |
Q66645332 | Work-related asthma from exposure to Cannabis sativa (marijuana and hemp) |
Q66477011 | microRNA in experimental models of chemical sensitization. |
Q21173555 | phenacyl chloride exposure | has effect | P1542 |
Q21112701 | respiratory sensitization | subclass of | P279 |
uri / http://www.wikidata.org/entity/L327495-S1 | L327495-S1 | item for this sense | P5137 |
Sensibilisierung (Immunologie) | wikipedia | |
Sensitization (immunology) | wikipedia | |
Persian (fa / Q9168) | حساسیتزایی (ایمنیشناسی) | wikipedia |
Érzékenyítés (immunológia) | wikipedia | |
Sensibilisatie | wikipedia | |
Сенсибилизация (иммунология) | wikipedia | |
Сенсибілізація (фізіологія) | wikipedia | |
uz | Sensibilizatsiya | wikipedia |
Search more.